Document is current
Any future updates will be listed below
-
Authors
Siriphanitchakorn, Tanamas
Ooi, Justin S. G.
Ng, Wy Ching
Tan, Hwee Cheng
Zhang, Summer L.
Ng, Dorothy H. L.
Yap, Xin
Yee, Jia Xin
Zheng, Qiao
Tan, Yi Ting
Ong, Eugenia Z.
Chan, Kuan Rong
Choy, Milly M.
Ooi, Eng Eong
-
Funding
Funding for this research was provided by:
The Singapore Translational Research Award administered by the National Medical Research Council of Singapore (MOH-001271-00)
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 3 February 2026
First Online: 17 February 2026
Competing interests
: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.
